Chapter 26. Controls on NHS Medicines Prescribing and Expenditure in the UK (A Historical Perspective) with some International Comparisons
- John P Griffin BSc, PhD, MBBS, FRCP, FRCPath, FFPM1,
- John O'Grady MD, FRCP, FFPM, FBIRA, MRCPath2
Published Online: 25 OCT 2007
DOI: 10.1002/9780470987391.ch26
© 2006 by Blackwell Publishing Ltd.
Book Title

The Textbook of Pharmaceutical Medicine, Fifth Edition
Additional Information
How to Cite
Griffin, J. P. and Griffin, J. R. (2007) Controls on NHS Medicines Prescribing and Expenditure in the UK (A Historical Perspective) with some International Comparisons, in The Textbook of Pharmaceutical Medicine, Fifth Edition (eds J. P. Griffin and J. O'Grady), Blackwell Publishing Ltd, Oxford, UK. doi: 10.1002/9780470987391.ch26
Editor Information
- 1
Director, Asklepieion Consultancy Ltd., Visiting Professor, University of Surrey Postgraduate Medical School, Former Director, Association of the British Pharmaceutical Industry, London, Formerly Professional Head of the Medicines Division, DHSS, London
- 2
Visiting Professor of Clinical Pharmacology, University of London
Publication History
- Published Online: 25 OCT 2007
- Published Print: 15 DEC 2005
ISBN Information
Print ISBN: 9780727918406
Online ISBN: 9780470987391
- Summary
- Chapter
- References
Keywords:
- marketing authorisation;
- product licence;
- good manufacturing practice;
- national health service;
- United Kingdom
Summary
This chapter contains sections titled:
Introduction
The NHS and Community Care Act 1990
The Problem of the Rising NHS Medicines Bill
Prescription Charges for NHS Medicines
The Pharmaceutical Price Regulation Scheme
The Drug Tariff and Reference Pricing
Contract Purchase of Medicines from Cheap Sources
The MacGregor Committee
Generic Substitution
Enforced Price Reductions
Limited or Selected Lists
The Indicative Prescribing Scheme and GP Fundholding
The Development of Primary Care Groups (PCGs)
Changing the Legal Status of Medicines from Prescription only to Over-the-Counter Availability
Encouragement to Prescribe Generically
The National Institute for Clinical Excellence
The European Transparency Directive
Supply of Controlled Drugs
The British National Formulary
International Comparisons
